| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Revenue from collaboration and licensing | ||||||
11,942 | 7,629 | - | ||||
Operating expenses: | ||||||
Research and development | ||||||
46,312 | 21,965 | 9,772 | ||||
General and administrative | ||||||
16,715 | 6,844 | 4,385 | ||||
Total operating expenses | ||||||
63,027 | 28,809 | 14,157 | ||||
Loss from operations | ||||||
-51,085 | -21,180 | -14,157 | ||||
Other income (expense): | ||||||
Grant income | ||||||
6,737 | 5,612 | 2,069 | ||||
Interest income | ||||||
1,587 | 0 | - | ||||
Interest expense | ||||||
877 | 778 | 606 | ||||
Other income and expenses, net | ||||||
601 | 133 | -25 | ||||
Total other income, net | ||||||
8,048 | 4,967 | 1,438 | ||||
Net loss before tax | ||||||
-43,037 | -16,213 | -12,719 | ||||
Income tax expense | ||||||
0 | 24 | 4 | ||||
Net loss | ||||||
-43,037 | -16,237 | -12,723 | ||||
Other comprehensive loss: | ||||||
Foreign currency translation gain (loss), net of tax | ||||||
-933 | -2,358 | 1,764 | ||||
Comprehensive loss | ||||||
-43,970 | -18,595 | -10,959 | ||||
Net loss per share—basic and diluted | ||||||
-2.41 | -17.76 | -13.95 | ||||
Weighted average common shares outstanding — basic and diluted | ||||||
17,859 | 914 | 911 | ||||